Tokyo Kikai shareholders approve poison pill, setting up court battle
Reuters
Published Oct 23, 2021 02:29AM ET
By Makiko Yamazaki
TOKYO (Reuters) - Shareholders in Tokyo Kikai Seisakusho Ltd approved a "poison pill" measure on Friday aimed at blocking a takeover attempt by its top investor, setting up a court battle that will have sweeping implications for hostile bids in Japan.
Tokyo Kikai, a little known company that is the country's largest maker of newspaper printing presses, said a majority of its shareholders approved a measure that would dilute Asia Development Capital's (ADC) 40% stake.
ADC was excluded https://www.reuters.com/business/sustainable-business/court-battle-raises-question-how-far-will-japan-swallow-poison-pills-2021-10-21 from the vote and has already sought an injunction to nullify it. Had investors voted on Friday against the poison pill it would have handed ADC a victory.
About 79% of the votes supported the poison pill, Tokyo Kikai said in a statement. ADC said Tokyo Kikai would have lost if ADC had not been excluded, as the number of votes cast for the poison pill were fewer than those ADC could have cast alone.
Now, focus will turn to the injunction and the Tokyo District Court ruling expected next week that will be the first to examine an attempt to exclude an investor from a shareholder vote on a poison pill.
A victory for Tokyo Kikai would potentially make it easier for other Japanese companies to use poison pills.
Tokyo Kikai has said ADC hurts its corporate value, while the fund argues that a ruling in Tokyo Kikai's favour would fly in the face of shareholder equality.
The battle highlights both a rise in hostile takeovers in Japan over the past few years and what some experts see as inadequate takeover rules that leave companies, especially small ones, with few defences against hostile bids.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.